Perceptive Advisors LLC 13D and 13G filings for Landos Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-03-30 4:44 pm Unchanged | 2023-03-23 | 13D | Landos Biopharma, Inc. LABP | Perceptive Advisors LLC | 1,486,992 47.700% | 0 (Unchanged) | Filing |
| 2023-01-13 5:07 pm Unchanged | 2023-01-10 | 13D | Landos Biopharma, Inc. LABP | Perceptive Advisors LLC | 1,486,992 36.900% | 0 (Unchanged) | Filing |
| 2022-08-09 09:15 am Sale | 2022-08-09 | 13D | Landos Biopharma, Inc. LABP | Perceptive Advisors LLC | 1,486,992 36.900% | -309,092 (-17.21%) | Filing |
| 2021-04-06 5:00 pm Unchanged | 2021-03-31 | 13D | Landos Biopharma, Inc. LABP | Perceptive Advisors LLC | 1,796,084 44.800% | 0 (Unchanged) | Filing |
| 2021-02-18 5:15 pm Purchase | 2021-02-08 | 13D | Landos Biopharma, Inc. LABP | Perceptive Advisors LLC | 1,796,084 45.900% | 1,796,084 (New Position) | Filing |